IBDEI21Z ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32770,1,3,0)
 ;;=3^OAG w/ Boderline Findings,High Risk,OD
 ;;^UTILITY(U,$J,358.3,32770,1,4,0)
 ;;=4^H40.021
 ;;^UTILITY(U,$J,358.3,32770,2)
 ;;=^5005728
 ;;^UTILITY(U,$J,358.3,32771,0)
 ;;=H40.022^^128^1669^11
 ;;^UTILITY(U,$J,358.3,32771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32771,1,3,0)
 ;;=3^OAG w/ Boderline Findings,High Risk,OS
 ;;^UTILITY(U,$J,358.3,32771,1,4,0)
 ;;=4^H40.022
 ;;^UTILITY(U,$J,358.3,32771,2)
 ;;=^5005729
 ;;^UTILITY(U,$J,358.3,32772,0)
 ;;=H40.052^^128^1669^2
 ;;^UTILITY(U,$J,358.3,32772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32772,1,3,0)
 ;;=3^OHTN,OS
 ;;^UTILITY(U,$J,358.3,32772,1,4,0)
 ;;=4^H40.052
 ;;^UTILITY(U,$J,358.3,32772,2)
 ;;=^5005741
 ;;^UTILITY(U,$J,358.3,32773,0)
 ;;=H40.051^^128^1669^1
 ;;^UTILITY(U,$J,358.3,32773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32773,1,3,0)
 ;;=3^OHTN,OD
 ;;^UTILITY(U,$J,358.3,32773,1,4,0)
 ;;=4^H40.051
 ;;^UTILITY(U,$J,358.3,32773,2)
 ;;=^5005740
 ;;^UTILITY(U,$J,358.3,32774,0)
 ;;=H40.053^^128^1669^3
 ;;^UTILITY(U,$J,358.3,32774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32774,1,3,0)
 ;;=3^OHTN,OU
 ;;^UTILITY(U,$J,358.3,32774,1,4,0)
 ;;=4^H40.053
 ;;^UTILITY(U,$J,358.3,32774,2)
 ;;=^5005742
 ;;^UTILITY(U,$J,358.3,32775,0)
 ;;=H40.003^^128^1669^6
 ;;^UTILITY(U,$J,358.3,32775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32775,1,3,0)
 ;;=3^Pre-GLC OU,Unspec
 ;;^UTILITY(U,$J,358.3,32775,1,4,0)
 ;;=4^H40.003
 ;;^UTILITY(U,$J,358.3,32775,2)
 ;;=^5005722
 ;;^UTILITY(U,$J,358.3,32776,0)
 ;;=H40.002^^128^1669^5
 ;;^UTILITY(U,$J,358.3,32776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32776,1,3,0)
 ;;=3^Pre-GLC OS,Unspec
 ;;^UTILITY(U,$J,358.3,32776,1,4,0)
 ;;=4^H40.002
 ;;^UTILITY(U,$J,358.3,32776,2)
 ;;=^5005721
 ;;^UTILITY(U,$J,358.3,32777,0)
 ;;=H40.001^^128^1669^4
 ;;^UTILITY(U,$J,358.3,32777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32777,1,3,0)
 ;;=3^Pre-GLC OD,Unspec
 ;;^UTILITY(U,$J,358.3,32777,1,4,0)
 ;;=4^H40.001
 ;;^UTILITY(U,$J,358.3,32777,2)
 ;;=^5005720
 ;;^UTILITY(U,$J,358.3,32778,0)
 ;;=H40.043^^128^1669^18
 ;;^UTILITY(U,$J,358.3,32778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32778,1,3,0)
 ;;=3^Steroid Responder,OU
 ;;^UTILITY(U,$J,358.3,32778,1,4,0)
 ;;=4^H40.043
 ;;^UTILITY(U,$J,358.3,32778,2)
 ;;=^5005738
 ;;^UTILITY(U,$J,358.3,32779,0)
 ;;=H40.042^^128^1669^17
 ;;^UTILITY(U,$J,358.3,32779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32779,1,3,0)
 ;;=3^Steroid Responder,OS
 ;;^UTILITY(U,$J,358.3,32779,1,4,0)
 ;;=4^H40.042
 ;;^UTILITY(U,$J,358.3,32779,2)
 ;;=^5005737
 ;;^UTILITY(U,$J,358.3,32780,0)
 ;;=H40.041^^128^1669^16
 ;;^UTILITY(U,$J,358.3,32780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32780,1,3,0)
 ;;=3^Steroid Responder,OD
 ;;^UTILITY(U,$J,358.3,32780,1,4,0)
 ;;=4^H40.041
 ;;^UTILITY(U,$J,358.3,32780,2)
 ;;=^5005736
 ;;^UTILITY(U,$J,358.3,32781,0)
 ;;=H40.53X4^^128^1670^46
 ;;^UTILITY(U,$J,358.3,32781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32781,1,3,0)
 ;;=3^GLC 2nd to Oth Eye d/o,OU,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,32781,1,4,0)
 ;;=4^H40.53X4
 ;;^UTILITY(U,$J,358.3,32781,2)
 ;;=^5005900
 ;;^UTILITY(U,$J,358.3,32782,0)
 ;;=H40.53X1^^128^1670^43
 ;;^UTILITY(U,$J,358.3,32782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32782,1,3,0)
 ;;=3^GLC 2nd to Oth Eye d/o,OU,Mild Stage
 ;;^UTILITY(U,$J,358.3,32782,1,4,0)
 ;;=4^H40.53X1
